People and Business News – 6/23
The latest people and business news from the past month, all in one place.
People News
DM Clinical Research announced the hiring of Wes Bonner as VP of Strategic Relationships. Previously, Bonner held various leadership roles with Meridian Clinical Research for 10 years.
HeartcoR Solutions announced the promotion of two company executives. Cesar Patino will start as director of project management and Henry Flores will move into a newly created position as director of device and application portfolio.
Emmes announced the addition of Kristin Judge as chief growth officer, a newly created role. Previously, she served as head of CRO and clinical data management systems sales at Veeva Systems, leading a global team responsible for more than 200 customers across both the CRO and biotech sectors.
Phastar announced that statistics manager Stephen Corson has been chosen to receive the DIA 2023 Global Inspire Award for Community Engagement and advancing thought leadership within the membership community.
DM Clinical Research announced the recruitment of Stephanie Ailey as VP of business development. Prior to joining DM Clinical Research, she served as VP of business development with both Velocity Clinical Research and Meridian Clinical Research.
Beaconcure announced the appointment of Rick Riegel as board chairman. Additionally, Riegel worked to assemble an advisory board that includes Craig Lipset, John Oidtman, and Irving Dark.
Business News
Clario announced the implementation of over 30 new AI solutions, aiming to provide faster data analysis.
Worldwide Clinical Trials expanded its site alliance collaboration with new partners across North America and Europe.
Aixial Group has fully integrated Cmed and Larix to become a mid-size CRO with more than 1,000 employees.
Centricity Research has announced a major clinical trials investment from Trinity Hunt Partners.
Almac Group announced a 14.3% rise in revenue, marking its most financially successful year to date.
WCG announced a company rebrand, aimed at elevating the company’s identity and supporting their mission of improving lives through accelerating research.
Unlock Commercial Growth through Data-Driven Patient and HCP Insights
May 2nd 2025Leveraging data-driven patient and healthcare provider (HCP) insights, including social drivers of health (SDOH), is essential for life sciences companies to continuously improve patient engagement and commercial success. Mark Rodgers, AVP of Commercial Analytics at Inovalon, discusses how identifying treatment milestones, assessing HCP performance, and segmenting patient populations using SDOH data can drive targeted strategies that improve healthcare outcomes and market access
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.
